Exact Mass: 446.1315

Exact Mass Matches: 446.1315

Found 70 metabolites which its exact mass value is equals to given mass value 446.1315, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Febantel

Febantel

C20H22N4O6S (446.126)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

   

Febantel

N-{2-[(di{[hydroxy(methoxy)methylidene]amino}methylidene)amino]-5-(phenylsulphanyl)phenyl}-2-methoxyethanimidic acid

C20H22N4O6S (446.126)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C250 - Antihelminthic Agent

   

Nesbuvir

5-Cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulphonyl)amino]-N-methyl-1-benzofuran-3-carboxamide

C22H23FN2O5S (446.1312)


C471 - Enzyme Inhibitor > C25995 - RNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

Antibiotic CL 1565T

Antibiotic CL 1565T

C19H27O10P (446.1342)


   

Longicaudatin

Longicaudatin

C26H22O7 (446.1365)


   
   

MCULE-9275123054

MCULE-9275123054

C21H22N2O9 (446.1325)


   

Triquetrumone B

Triquetrumone B

C26H22O7 (446.1365)


   

dichotomine I|methyl 1-acetyl-8-(beta-D-glucopyranosyloxy)-9H-beta-carboline-3-carboxylate

dichotomine I|methyl 1-acetyl-8-(beta-D-glucopyranosyloxy)-9H-beta-carboline-3-carboxylate

C21H22N2O9 (446.1325)


   
   

1-oxo-4-demethoxy-3,4-methylenedioxyrocaglaol

1-oxo-4-demethoxy-3,4-methylenedioxyrocaglaol

C26H22O7 (446.1365)


   
   

N-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-N-methyl-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide

NCGC00347866-02!N-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-N-methyl-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide

C21H22N2O9 (446.1325)


   

Trichodermamide C

N-(7,8-Dimethoxy-2-oxo-2H-chromen-3-yl)-4a,5,8-trihydroxy-N-methyl-4a,5,8,8a-tetrahydro-4H-1,2-benzoxazine-3-carboxamide

C21H22N2O9 (446.1325)


CONFIDENCE isolated standard

   

N-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-N-methyl-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide [IIN-based: Match]

NCGC00347866-02!N-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-N-methyl-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide [IIN-based: Match]

C21H22N2O9 (446.1325)


   

N-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-N-methyl-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide [IIN-based on: CCMSLIB00000848485]

NCGC00347866-02!N-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-N-methyl-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide [IIN-based on: CCMSLIB00000848485]

C21H22N2O9 (446.1325)


   

Cys Gly His Met

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C16H26N6O5S2 (446.1406)


   

Cys Gly Met His

(2S)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanoic acid

C16H26N6O5S2 (446.1406)


   

Cys His Gly Met

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}-4-(methylsulfanyl)butanoic acid

C16H26N6O5S2 (446.1406)


   

Cys His Met Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]acetic acid

C16H26N6O5S2 (446.1406)


   

Cys Met Gly His

(2S)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C16H26N6O5S2 (446.1406)


   

Cys Met His Gly

2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C16H26N6O5S2 (446.1406)


   

Gly Cys His Met

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanoic acid

C16H26N6O5S2 (446.1406)


   

Gly Cys Met His

(2S)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanoic acid

C16H26N6O5S2 (446.1406)


   

Gly His Cys Met

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C16H26N6O5S2 (446.1406)


   

Gly His Met Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C16H26N6O5S2 (446.1406)


   

Gly Met Cys His

(2S)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C16H26N6O5S2 (446.1406)


   

Gly Met His Cys

(2R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C16H26N6O5S2 (446.1406)


   

His Cys Gly Met

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]acetamido}-4-(methylsulfanyl)butanoic acid

C16H26N6O5S2 (446.1406)


   

His Cys Met Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-(methylsulfanyl)butanamido]acetic acid

C16H26N6O5S2 (446.1406)


   

His Gly Cys Met

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-sulfanylpropanamido]-4-(methylsulfanyl)butanoic acid

C16H26N6O5S2 (446.1406)


   

His Gly Met Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]acetamido}-4-(methylsulfanyl)butanamido]-3-sulfanylpropanoic acid

C16H26N6O5S2 (446.1406)


   

His Met Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]acetic acid

C16H26N6O5S2 (446.1406)


   

His Met Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-(methylsulfanyl)butanamido]acetamido}-3-sulfanylpropanoic acid

C16H26N6O5S2 (446.1406)


   

Met Cys Gly His

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]acetamido}-3-(1H-imidazol-4-yl)propanoic acid

C16H26N6O5S2 (446.1406)


   

Met Cys His Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]acetic acid

C16H26N6O5S2 (446.1406)


   

Met Gly Cys His

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C16H26N6O5S2 (446.1406)


   

Met Gly His Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C16H26N6O5S2 (446.1406)


   

Met His Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]acetic acid

C16H26N6O5S2 (446.1406)


   

Met His Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-(1H-imidazol-4-yl)propanamido]acetamido}-3-sulfanylpropanoic acid

C16H26N6O5S2 (446.1406)


   

1,3,5-TRI-O-BENZOYL-2-DEOXY-2-FLUORO-α-D-ARABINOFURANOSE

1,3,5-TRI-O-BENZOYL-2-DEOXY-2-FLUORO-α-D-ARABINOFURANOSE

C26H22O7 (446.1365)


   

1,5-DIBENZAMIDOANTHRAQUINONE

1,5-DIBENZAMIDOANTHRAQUINONE

C28H18N2O4 (446.1267)


   

hydroxyzine hydrochloride

Hydroxyzine dihydrochloride

C21H29Cl3N2O2 (446.1295)


D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D003879 - Dermatologic Agents > D000982 - Antipruritics Hydroxyzine dihydrochloride, a benzodiazepine antihistamine agent, acts as a orally active histamine?H1-receptor and serotonin antagonist. Hydroxyzine dihydrochloride has anxiolytic effect and can be used forthe research of generalised anxiety disorder[1][2].

   

tributyl-[5-(1,3-dioxolan-2-yl)thiophen-2-yl]stannane

tributyl-[5-(1,3-dioxolan-2-yl)thiophen-2-yl]stannane

C19H34O2SSn (446.1301)


   
   

2-(2-methylpropoxy)ethyl 2-(2-cyanoethylamino)-5-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzoate

2-(2-methylpropoxy)ethyl 2-(2-cyanoethylamino)-5-[(5-nitro-1,3-thiazol-2-yl)diazenyl]benzoate

C19H22N6O5S (446.1372)


   
   

N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide

N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide

C26H23ClN2O3 (446.1397)


   

o-bis(diphenylphosphino)benzene

o-bis(diphenylphosphino)benzene

C30H24P2 (446.1353)


   

N-(7,8-Dimethoxy-2-oxochromen-3-YL)-4A,5,8-trihydroxy-N-methyl-4,5,8,8A-tetrahydro-1,2-benzoxazine-3-carboxamide

N-(7,8-Dimethoxy-2-oxochromen-3-YL)-4A,5,8-trihydroxy-N-methyl-4,5,8,8A-tetrahydro-1,2-benzoxazine-3-carboxamide

C21H22N2O9 (446.1325)


   

Nesbuvir

Nesbuvir

C22H23FN2O5S (446.1312)


C471 - Enzyme Inhibitor > C25995 - RNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

2-[2-[[(2S)-2-azaniumyl-2-carboxylatoethyl]amino]-2-oxoethyl]-4-[2-[(4-carboxylato-4-oxobutanoyl)amino]ethylamino]-2-hydroxy-4-oxobutanoate

2-[2-[[(2S)-2-azaniumyl-2-carboxylatoethyl]amino]-2-oxoethyl]-4-[2-[(4-carboxylato-4-oxobutanoyl)amino]ethylamino]-2-hydroxy-4-oxobutanoate

C16H22N4O11-2 (446.1285)


   

2-[2-[4-[(4-Chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol;hydron;dichloride

2-[2-[4-[(4-Chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol;hydron;dichloride

C21H29Cl3N2O2 (446.1295)


D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D003879 - Dermatologic Agents > D000982 - Antipruritics

   

3-L-valyl-AMP

3-L-valyl-AMP

C15H23N6O8P (446.1315)


An L-valyl ester obtained by formal condensation of the carboxy group of L-valine with the 3-hydroxy group of AMP.

   

2-[4-[(E)-3-[2-[(4-methoxycarbonylphenyl)methoxy]phenyl]prop-2-enoyl]phenoxy]acetic acid

2-[4-[(E)-3-[2-[(4-methoxycarbonylphenyl)methoxy]phenyl]prop-2-enoyl]phenoxy]acetic acid

C26H22O7 (446.1365)


   

2-[(4-Chloro-3-nitrophenyl)-oxomethyl]benzoic acid [2-[di(propan-2-yl)amino]-2-oxoethyl] ester

2-[(4-Chloro-3-nitrophenyl)-oxomethyl]benzoic acid [2-[di(propan-2-yl)amino]-2-oxoethyl] ester

C22H23ClN2O6 (446.1245)


   

ethyl 6-amino-5-cyano-2-[(3-cyano-4,6-dimethylpyridin-2-yl)sulfanylmethyl]-4-phenyl-4H-pyran-3-carboxylate

ethyl 6-amino-5-cyano-2-[(3-cyano-4,6-dimethylpyridin-2-yl)sulfanylmethyl]-4-phenyl-4H-pyran-3-carboxylate

C24H22N4O3S (446.1413)


   

5-[(2-{[(3S)-5-{[(2S)-2-azaniumyl-2-carboxylatoethyl]amino}-3-carboxylato-3-hydroxy-5-oxopentanoyl]amino}ethyl)amino]-2,5-dioxopentanoate

5-[(2-{[(3S)-5-{[(2S)-2-azaniumyl-2-carboxylatoethyl]amino}-3-carboxylato-3-hydroxy-5-oxopentanoyl]amino}ethyl)amino]-2,5-dioxopentanoate

C16H22N4O11-2 (446.1285)


   

staphyloferrin B(2-)

staphyloferrin B(2-)

C16H22N4O11 (446.1285)


A tricarboxylic acid dianion obtained by deprotonation of the three carboxy groups and protonation of the amino group of staphyloferrin B; major species at pH 7.3.

   
   

(2r,5s,6r)-6-(2h-1,3-benzodioxol-5-yl)-2-hydroxy-10,12-dimethoxy-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-trien-3-one

(2r,5s,6r)-6-(2h-1,3-benzodioxol-5-yl)-2-hydroxy-10,12-dimethoxy-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-trien-3-one

C26H22O7 (446.1365)


   

6-(2h-1,3-benzodioxol-5-yl)-2-hydroxy-10,12-dimethoxy-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-trien-3-one

6-(2h-1,3-benzodioxol-5-yl)-2-hydroxy-10,12-dimethoxy-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-trien-3-one

C26H22O7 (446.1365)


   

(4as,5r,8r,8as)-n-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-n-methyl-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide

(4as,5r,8r,8as)-n-(7,8-dimethoxy-2-oxochromen-3-yl)-4a,5,8-trihydroxy-n-methyl-4,5,8,8a-tetrahydro-1,2-benzoxazine-3-carboxamide

C21H22N2O9 (446.1325)


   

11,17-dihydroxy-7,7,10,20,20-pentamethyl-2,8,19,25-tetraoxahexacyclo[12.11.0.0³,¹².0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosa-1(14),3,5,9,11,15(24),16,18(23),21-nonaen-13-one

11,17-dihydroxy-7,7,10,20,20-pentamethyl-2,8,19,25-tetraoxahexacyclo[12.11.0.0³,¹².0⁴,⁹.0¹⁵,²⁴.0¹⁸,²³]pentacosa-1(14),3,5,9,11,15(24),16,18(23),21-nonaen-13-one

C26H22O7 (446.1365)


   

[(1e,3r,4r,6r,7z,9z,11e)-3,6,13-trihydroxy-1-[(2s)-3-hydroxy-6-oxo-2,3-dihydropyran-2-yl]-3-methyltrideca-1,7,9,11-tetraen-4-yl]oxyphosphonic acid

[(1e,3r,4r,6r,7z,9z,11e)-3,6,13-trihydroxy-1-[(2s)-3-hydroxy-6-oxo-2,3-dihydropyran-2-yl]-3-methyltrideca-1,7,9,11-tetraen-4-yl]oxyphosphonic acid

C19H27O10P (446.1342)


   

(5r,8r)-2-(hexa-2,4-diyn-1-ylidene)-1,6-dioxaspiro[4.5]dec-3-en-8-yl (2s)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate

(5r,8r)-2-(hexa-2,4-diyn-1-ylidene)-1,6-dioxaspiro[4.5]dec-3-en-8-yl (2s)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate

C24H21F3O5 (446.1341)


   

(5r,8r)-2-(hexa-2,4-diyn-1-ylidene)-1,6-dioxaspiro[4.5]dec-3-en-8-yl (2r)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate

(5r,8r)-2-(hexa-2,4-diyn-1-ylidene)-1,6-dioxaspiro[4.5]dec-3-en-8-yl (2r)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate

C24H21F3O5 (446.1341)


   

(2e,5r,8r)-2-(hexa-2,4-diyn-1-ylidene)-1,6-dioxaspiro[4.5]dec-3-en-8-yl (2s)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate

(2e,5r,8r)-2-(hexa-2,4-diyn-1-ylidene)-1,6-dioxaspiro[4.5]dec-3-en-8-yl (2s)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate

C24H21F3O5 (446.1341)


   

(2e,5r,8r)-2-(hexa-2,4-diyn-1-ylidene)-1,6-dioxaspiro[4.5]dec-3-en-8-yl (2r)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate

(2e,5r,8r)-2-(hexa-2,4-diyn-1-ylidene)-1,6-dioxaspiro[4.5]dec-3-en-8-yl (2r)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate

C24H21F3O5 (446.1341)